Therapeutic Asset Ratings
18,153 results matching 1 filter
91,564 assets · 7,904 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Etoposide
Ovarian Germ Cell Tumor
Nabil Adra
P3
BB
(68)
Etoposide
Squamous Cell Lung Carcinoma
Barbara Ann Karmanos Cancer Institute
P3
BB
(68)
Famitinib
Triple-Negative Breast Carcinoma
Fudan University
P3
BB
(68)
Fludarabine
Graft Versus Host Disease
City of Hope Medical Center
P3
BB
(68)
Fludarabine
Indolent B-Cell Non-Hodgkin Lymphoma
Institute of Hematology & Blood Diseases Hospital, China
P3
BB
(68)
Fludarabine
T-Cell And NK-Cell Neoplasm
Masonic Cancer Center, University of Minnesota
P3
BB
(68)
Fluorouracilum
Peritoneal Carcinomatosis
Ciusss de L'Est de l'Île de Montréal
P3
BB
(68)
Fluorouracilum
Primary Peritoneal Carcinoma
National Cancer Institute (NCI)
P3
BB
(68)
Fluorouracilum
Rectal Neoplasm
Pei-Rong Ding
P3
BB
(68)
Flutamide
Prostate Adenocarcinoma
NRG Oncology
P3
BB
(68)
Gozetotide
Prostate Neoplasm
Telix Pharmaceuticals (Innovations) Pty Limited
P3
BB
(68)
Hydralazine
Essential Hypertension
ProMedica Health System
P3
BB
(68)
Hydrocortisone
Adrenocortical Insufficiency
Vastra Gotaland Region
P3
BB
(68)
Hydrocortisone
Myelodysplastic Syndrome
Andrew E. Place, MD
P3
BB
(68)
Hydrocortisone
Childhood Acute Lymphoblastic Leukemia
Children's Oncology Group
P3
BB
(68)
Ibrutinib
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
The First Affiliated Hospital with Nanjing Medical University
P3
BB
(68)
Indocyanine Green
Rectal Cancer
National Cancer Center, China
P3
BB
(68)
Irinotecan
Colon Carcinoma
SCRI Development Innovations, LLC
P3
BB
(68)
Irinotecan
Fallopian Tube Cancer
Tianjin Medical University Cancer Institute and Hospital
P3
BB
(68)
Irinotecan
Glioblastoma
University of Cincinnati
P3
BB
(68)
Irinotecan
Gliosarcoma
RTOG Foundation, Inc.
P3
BB
(68)
Irinotecan
Metastasis From Malignant Tumor Of Colon
Jun Huang
P3
BB
(68)
Irinotecan
Lung Cancer
City of Hope Medical Center
P3
BB
(68)
Lazertinib
Non-Small Cell Lung Carcinoma
Janssen Research & Development, LLC
P3
BB
(68)
Lenalidomide
Diffuse Large B-Cell Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.
P3
BB
(68)
Showing 1801 to 1825 of 18,153 assets
Previous
Page 73 of 727
Next